{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:17:57Z","timestamp":1790983077721,"version":"4.1.0"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.6752-25","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T22:09:55Z","timestamp":1786140595000},"source":"Crossref","is-referenced-by-count":1,"title":["DRESS during chemotherapy with carboplatin, pemetrexed, and osimertinib for lung adenocarcinoma: A case report"],"prefix":"10.2169","author":[{"given":"Naoki","family":"Okada","sequence":"first","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Takiguchi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Ikoma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyu","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanami","family":"Hirasawa","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Uotani","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Umemoto","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Horio","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hayama","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Oguma","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Asano","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Calle AM, Aguirre N, Ardila JC, Cardona Villa R. DRESS syndrome: A literature review and treatment algorithm. World Allergy Organ J 16 (3): 100673, 2023 (in eng).","DOI":"10.1016\/j.waojou.2022.100673"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kaur S, Singh S, Singh R, Singla P. DRESS syndrome induced by imatinib. J Postgrad Med 67 (3): 158-163, 2021 (in eng).","DOI":"10.4103\/jpgm.JPGM_746_20"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Park H, Choi GS, Lee EM. Successful Treatment of Imatinib-Induced DRESS Syndrome Using Reslizumab without Cessation of Imatinib: A Case Report. Case Rep Oncol 14 (3): 1548-1554, 2021 (in eng).","DOI":"10.1159\/000519471"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lin CF, Liu SY, Lo TK, Lee JY, Su PL. Successful erlotinib rechallenge in an EGFR-mutant metastatic non-small cell lung cancer patient with afatinib-induced drug rash with eosinophilia and systemic symptoms: A case report. Thorac Cancer 13 (3): 494-496, 2022 (in eng).","DOI":"10.1111\/1759-7714.14276"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ferreira SC, Gaspar C, Dion\u00edsio J, Moura C, Almodovar T. Drug reaction with eosinophilia and systemic symptoms syndrome associated with osimertinib. Pulmonology 27 (3): 266-267, 2021 (in eng).","DOI":"10.1016\/j.pulmoe.2020.07.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Oyama B, Morikawa K, Sakaguchi T, et al. Drug-induced Hypersensitivity Syndrome by EGFR-TKI in a Patient with Lung Cancer. Intern Med 60 (3): 441-444, 2021 (in eng).","DOI":"10.2169\/internalmedicine.4237-19"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lian BS, Ha JH, Sultana R, et al. Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis. Am J Clin Dermatol 24 (4): 637-647, 2023 (in eng).","DOI":"10.1007\/s40257-023-00776-6"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Ishida T, Kano Y, Mizukawa Y, Shiohara T. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome. Allergy 69 (6): 798-805, 2014 (in eng).","DOI":"10.1111\/all.12410"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chen YC, Chang CY, Cho YT, Chiu HC, Chu CY. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol 68 (3): 459-465, 2013 (in eng).","DOI":"10.1016\/j.jaad.2012.08.009"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169 (5): 1071-1080, 2013 (in eng).","DOI":"10.1111\/bjd.12501"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 55 (1): 1-8, 2006 (in eng).","DOI":"10.2332\/allergolint.55.1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156 (5): 1083-1084, 2007 (in eng).","DOI":"10.1111\/j.1365-2133.2007.07807.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mizukawa Y, Hirahara K, Kano Y, Shiohara T. Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J Am Acad Dermatol 80 (3): 670-678.e672, 2019 (in eng).","DOI":"10.1016\/j.jaad.2018.08.052"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Planchard D, J\u00e4nne PA, Cheng Y, et al. Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC. N Engl J Med 389 (21): 1935-1948, 2023 (in eng).","DOI":"10.1056\/NEJMoa2306434"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 124 (7): 588-597, 2011 (in eng).","DOI":"10.1016\/j.amjmed.2011.01.017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hung SI, Chung WH, Jee SH, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 16 (4): 297-306, 2006 (in eng).","DOI":"10.1097\/01.fpc.0000199500.46842.4a"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 131 (5): 544-551, 1995 (in eng).","DOI":"10.1001\/archderm.1995.01690170046006"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int 68 (3): 301-308, 2019 (in eng).","DOI":"10.1016\/j.alit.2019.03.006"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chan LCE, Sultana R, Choo KJL, Yeo YW, Pang SM, Lee HY. Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Sci Rep 14 (1): 28492, 2024 (in eng).","DOI":"10.1038\/s41598-024-69054-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Miyagawa F, Asada H. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome\/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS\/DRESS). Int J Mol Sci 22 (4): 2021 (in eng).","DOI":"10.3390\/ijms22042147"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zhu H, Ren V. Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review. J Cutan Med Surg 27 (4): 388-398, 2023 (in eng).","DOI":"10.1177\/12034754231177590"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Caba\u00f1as R, Calder\u00f3n O, Ram\u00edrez E, et al. Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment. Clin Exp Allergy 48 (3): 325-333, 2018 (in eng).","DOI":"10.1111\/cea.13076"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chen CB, Wu MY, Ng CY, et al. Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies. Cancer Manag Res 10: 1259-1273, 2018 (in eng).","DOI":"10.2147\/CMAR.S163391"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 140 (2): 183-188, 2004 (in eng).","DOI":"10.1001\/archderm.140.2.183"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Targeting immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discov 23 (6): 445-460, 2024 (in eng).","DOI":"10.1038\/s41573-024-00920-9"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6752-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:06:20Z","timestamp":1786161980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6752-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6752-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"6752-25"}}